Q-Med has Received the Second Payment of $53.3 million from Medicis
December 19, 2003 03:27 ET
|
Q-Med
UPPSALA, Sweden, Dec. 19, 2003 (PRIMEZONE) -- With reference to that the American regulatory authority, Food And Drug Administration, FDA, has approved RESTYLANE for sales in USA, Q-Med has now...
RESTYLANE approved for sales in USA
December 13, 2003 12:12 ET
|
Q-Med
UPPSALA, Sweden, Dec. 12, 2003 (PRIMEZONE) -- The FDA (Food and Drug Administration), the American regulatory authority, has approved RESTYLANE for sales in USA.
The FDA's approval of RESTYLANE...
Q-Med: ZUIDEX obtains reimbursement in German hospitals
December 09, 2003 11:13 ET
|
Q-Med
UPPSALA, Sweden, Dec. 9, 2003 (PRIMEZONE) -- The German authorities have decided that treatment by injection for urinary incontinence shall be included in the so-called Diagnosis Related Groups...
The FDA's advisory panel recommends approval of RESTYLANE
November 21, 2003 14:32 ET
|
Q-Med
STOCKHOLM, Sweden, Nov. 21, 2003 (PRIMEZONE) -- The FDA, Food and Drug Administration, the American regulatory authority, convened an advisory panel on Friday with some of the world's leading experts...
Q-Med Interim report January -- September 2003
October 17, 2003 04:35 ET
|
Q-Med
UPPSALA, Sweden, Oct. 17, 2003 (PRIMEZONE) -- Q-Med (Other OTC:QMDAF):
- Turnover during the first nine months amounted to SEK 427.8 (369.5) million, of which SEK 145.1 (116.1) million was during...
Q-Med -- FDA confirms panel for RESTYLANE
September 17, 2003 03:56 ET
|
Q-Med
UPPSALA, Sweden, Sept. 17, 2003 (PRIMEZONE) -- Q-Med (Other OTC:QMDAF): The American regulatory authority FDA, Food and Drug Administration, has now confirmed that RESTYLANE is scheduled for an...
Q-Med: RESTYLANE might be discussed in a panel discussion
September 11, 2003 04:52 ET
|
Q-Med
UPPSALA, Sweden, Sept. 11, 2003 (PRIMEZONE) -- Q-Med AB has for some time had discussion with the American regulatory authority FDA, Food and Drug Administration, regarding a possible advisory panel...
Q-Med receives FDA approval to initiate the ZUIDEX clinical trial in the USA
September 08, 2003 05:19 ET
|
Q-Med
UPPSALA, Sweden, Sept. 8, 2003 (PRIMEZONE) -- Q-Med in Sweden has been informed by the FDA (Food and Drug Administration), the American regulatory authority, that the company's application to...
Q-Med AB: Interim report January -- June 2003
July 24, 2003 05:51 ET
|
Q-Med
UPPSALA, Sweden, July 24, 2003 (PRIMEZONE) -- Q-Med AB:
- Sales increased by 12 percent during the first six months. Adjusted for changes in exchange rates, sales increased by 20 percent.
-...
Annual General Meeting of the Shareholders of Q-Med AB (Publ)
May 12, 2003 14:14 ET
|
Q-Med
UPPSALA, Sweden, May 12, 2003 (PRIMEZONE) -- Q-Med Ab (Publ):
-- Pia Rudengren and Asa Roden, new members of the Board
-- No dividend for the financial year 2002
-- Nomination committee...